3d
The Texas Tribune on MSNA Republican effort to set deadlines to plug orphan wells in Texas hits resistanceThe bill would have set deadlines for the oil and gas industry to plug inactive wells, which can pose a danger to the ...
About a century ago, a comic strip called “Little Orphan Annie” began its decades-long run in newspapers. It was followed by ...
This week is World Orphan Week, and with it one group says the global crisis facing orphaned and vulnerable children demands ...
Korro Bio (NASDAQ:KRRO) said on Friday that it received U.S. FDA's orphan drug designation for investigational medicine ...
Korro Bio disclosed that the Food and Drug Administration granted orphan drug designation to its potential genetic disorder drug KRRO-110. Shares rose 17.6% to $29 in premarket trading. The stock is ...
8h
Tuko News on MSNTikToker Fake Tizian opens up on mum’s death, being caregiver to siblingsTikToker Fake Tizian opened up on his mum's death and being the family's provider. The young content creator revealed that ...
KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...
M'sian orphan, 15, spends S$0.75 a day on school meals, uses leftover change to buy food for grandma
Yet the 15-year-old would only spend RM2.5 (S$0.75) in school, using the leftover change to buy food for his grandmother. He ...
5d
Al-Monitor on MSNAdopted orphan brings couple 'paradise' in war-ravaged GazaIn their home in war-devastated Gaza City, Iman Farhat and her husband cherish the "paradise" brought by their newly-adopted ...
Operation BabyLift was a program to fly Vietnam orphans out of the country to America. Nearly 50 years later, an amazing bond has formed between a veteran and an orphan because of a teddy bear.
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results